Cargando…

Oncogenic KRAS mutations enhance amino acid uptake by colorectal cancer cells via the hippo signaling effector YAP1

Oncogenic KRAS mutations develop unique metabolic dependencies on nutrients to support tumor metabolism and cell proliferation. In particular, KRAS mutant cancer cells exploit amino acids (AAs) such as glutamine and leucine, to accelerate energy metabolism, redox balance through glutathione synthesi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kandasamy, Palanivel, Zlobec, Inti, Nydegger, Damian T., Pujol‐Giménez, Jonai, Bhardwaj, Rajesh, Shirasawa, Senji, Tsunoda, Toshiyuki, Hediger, Matthias A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486573/ https://www.ncbi.nlm.nih.gov/pubmed/34003553 http://dx.doi.org/10.1002/1878-0261.12999

Ejemplares similares

Applications of the Microscale Thermophoresis Binding Assay in COVID-19 Research
por: Nydegger, Damian T., et al.
Publicado: (2023)

Analysis of the relationship between the KRAS G12V oncogene and the Hippo effector YAP1 in embryonal rhabdomyosarcoma
por: Mohamed, Abdalla D., et al.
Publicado: (2018)

A novel proton transfer mechanism in the SLC11 family of divalent metal ion transporters
por: Pujol-Giménez, Jonai, et al.
Publicado: (2017)

YAP–VGLL4 antagonism defines the major physiological function of the Hippo signaling effector YAP
por: Cai, Jing, et al.
Publicado: (2022)

Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: from molecular discovery to clinical application
por: Gyimesi, Gergely, et al.
Publicado: (2020)

Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRAS(G13D) mutation
por: Charitou, Theodosia, et al.
Publicado: (2019)

Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous Melanoma
por: Nallet-Staub, Flore, et al.
Publicado: (2014)

The Hippo Pathway Effector YAP1 Regulates Intestinal Epithelial Cell Differentiation
por: Fallah, Sepideh, et al.
Publicado: (2020)

Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone
por: Isfort, Ilka, et al.
Publicado: (2019)

αE-catenin inhibits a Src–YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway
por: Li, Peng, et al.
Publicado: (2016)

Unraveling the structural elements of pH sensitivity and substrate binding in the human zinc transporter SLC39A2 (ZIP2)
por: Gyimesi, Gergely, et al.
Publicado: (2019)

Functional characterization of a highly specific l-arabinose transporter from Trichoderma reesei
por: Havukainen, Sami, et al.
Publicado: (2021)

Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis
por: Wang, Haichuan, et al.
Publicado: (2020)

Death domain–associated protein DAXX regulates noncoding RNA transcription at the centromere through the transcription regulator ZFAT
por: Ishikura, Shuhei, et al.
Publicado: (2022)

YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)

The Hippo pathway effector YAP is an essential regulator of ductal progenitor patterning in the mouse submandibular gland
por: Szymaniak, Aleksander D, et al.
Publicado: (2017)

Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell Function
por: Sun, Congshan, et al.
Publicado: (2017)

Modeling the Control of TGF-β/Smad Nuclear Accumulation by the Hippo Pathway Effectors, Taz/Yap
por: Labibi, Bita, et al.
Publicado: (2020)

Dedifferentiation by adenovirus E1A due to inactivation of Hippo pathway effectors YAP and TAZ
por: Zemke, Nathan R., et al.
Publicado: (2019)

The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth
por: Li, Xu, et al.
Publicado: (2022)

The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
por: Mokhtari, Reza Bayat, et al.
Publicado: (2023)

Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS-activated pancreatic cancer cells
por: Terado, Tokio, et al.
Publicado: (2022)

Mechanistic basis of the inhibition of SLC11/NRAMP-mediated metal ion transport by bis-isothiourea substituted compounds
por: Manatschal, Cristina, et al.
Publicado: (2019)

Normal Hematopoietic Stem Cell Function in Mice with Enforced Expression of the Hippo Signaling Effector YAP1
por: Jansson, Lina, et al.
Publicado: (2012)

Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effector
por: Xu, Jing, et al.
Publicado: (2016)

Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers
por: Marx, Andreas, et al.
Publicado: (2020)

Src family kinases inhibit differentiation of intestinal epithelial cells through the Hippo effector YAP1
por: Fallah, Sepideh, et al.
Publicado: (2021)

The Hippo Pathway Effectors YAP/TAZ Are Essential for Mineralized Tissue Homeostasis in the Alveolar Bone/Periodontal Complex
por: Pandya, Mirali, et al.
Publicado: (2022)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

ZFAT binds to centromeres to control noncoding RNA transcription through the KAT2B–H4K8ac–BRD4 axis
por: Ishikura, Shuhei, et al.
Publicado: (2020)

Electrophysiological characterization of a diverse group of sugar transporters from Trichoderma reesei
por: Havukainen, Sami, et al.
Publicado: (2021)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
por: Dobrokhotov, Oleg, et al.
Publicado: (2018)

Inhibitors of Human Divalent Metal Transporters DMT1 (SLC11A2) and ZIP8 (SLC39A8) from a GDB‐17 Fragment Library
por: Pujol‐Giménez, Jonai, et al.
Publicado: (2021)

Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth
por: Ragni, Chiara V., et al.
Publicado: (2017)

The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility
por: Al-Mathkour, Marwah M., et al.
Publicado: (2022)

Amotl2a interacts with the Hippo effector Yap1 and the Wnt/β-catenin effector Lef1 to control tissue size in zebrafish
por: Agarwala, Sobhika, et al.
Publicado: (2015)

The Multiple Interactions of RUNX with the Hippo–YAP Pathway
por: Chuang, Linda Shyue Huey, et al.
Publicado: (2021)

Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)

Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers
por: Ferraiuolo, Maria, et al.
Publicado: (2017)

CENP-B promotes the centromeric localization of ZFAT to control transcription of noncoding RNA
por: Ishikura, Shuhei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cg2f75g2lf92butdob3lnj2t4a